ผลงานวิจัยหน่วยโลหิตวิทยา

Division of Hematology(หน่วยโลหิตวิทยา)

2021

1. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Pasomsub E, Watcharananan SP, Boonyawat K, Janchompoo P, Wongtabtim G, Suksuwan W, Sungkanuparph S, Phuphuakrat A. Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4. doi: 10.1016/j.cmi.2020.05.001. Epub 2020 May 15. PMID: 32422408 Free PMC article.

2. A clinical and histological comparison between acute cutaneous graft-versus-host disease and other maculopapular eruptions following hematopoietic stem cell transplantation: a retrospective cohort. Chanprapaph K, Leerunyakul K, Niparuck P, Rutnin S. Int J Dermatol. 2021 Jan;60(1):60-69. doi: 10.1111/ijd.15186. Epub 2020 Sep 29. PMID: 32989780

3. Pregnancy-Associated Venous Thromboembolism: Insights from GARFIELD-VTE. Jerjes-Sánchez C, Rodriguez D, Farjat AE, Kayani G, MacCallum P, Lopes RD, Turpie AGG, Weitz JI, Haas S, Ageno W, Goto S, Goldhaber SZ, Angchaisuksiri P, Nielsen JD, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. TH Open. 2021 Jan 27;5(1):e24-e34. doi: 10.1055/s-0040-1722611. eCollection 2021 Jan. PMID: 33532693 Free PMC article.

4. Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD-VTE. Ageno W, Farjat A, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK. Res Pract Thromb Haemost. 2021 Feb 20;5(2):326-341. doi: 10.1002/rth2.12482. eCollection 2021 Feb. PMID: 33733032 Free PMC article.

5. Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE. Angchaisuksiri P, Goto S, Farjat AE, Fryk H, Bang SM, Chiang CE, Jing ZC, Kondo K, Sathar J, Tse E, Phusanti S, Kayani G, Weitz JI, Ageno W, Goldhaber SZ, Kakkar AK. Thromb Res. 2021 May;201:63-72. doi: 10.1016/j.thromres.2021.02.024. Epub 2021 Feb 24. PMID: 33652328

6. Adult aplastic anemia in Thailand: incidence and treatment outcome from a prospective nationwide population-based study. Norasetthada L, Wongkhantee S, Chaipokam J, Charoenprasert K, Chuncharunee S, Rojnuckarin P, Sirijerachai C, Wanachiwanawin W, Issaragrisil S; Thai Aplastic Anemia Study Group. Ann Hematol. 2021 Jul 16. doi: 10.1007/s00277-021-04566-0. Online ahead of print. PMID: 34269837

7. The influence of anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE. Goto S, Turpie AGG, Farjat AE, Weitz JI, Haas S, Ageno W, Goldhaber SZ, Angchaisuksiri P, Kayani G, MacCallum P, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Thromb Res. 2021 Jul;203:155-162. doi: 10.1016/j.thromres.2021.05.007. Epub 2021 May 15. PMID: 34023735 Free article.

8. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, Akl EA, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Schünemann HJ. Blood Adv. 2021 Feb 9;5(3):872-888. doi: 10.1182/bloodadvances.2020003763. PMID: 33560401 Free PMC article.

9. Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high- and low-dose rivaroxaban with aspirin. Boonyawat K, Lensing AWA, Prins MH, Beyer-Westendorf J, Prandoni P, Martinelli I, Middeldorp S, Pap AF, Weitz JI, Crowther M. Res Pract Thromb Haemost. 2021 Feb 17;5(2):308-313. doi: 10.1002/rth2.12474. eCollection 2021 Feb. PMID: 33733030 Free PMC article.

10. Influence of Body Mass Index on Clinical Outcomes in Venous Thromboembolism: Insights from GARFIELD-VTE. Weitz JI, Farjat AE, Ageno W, Turpie AG, Haas S, Goto S, Goldhaber SZ, Angchaisuksiri P, Gibbs H, MacCallum P, Carrier M, Kayani G, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. J Thromb Haemost. 2021 Sep 6. doi: 10.1111/jth.15520. Online ahead of print. PMID: 34487616

11. Comparison between blood hemoglobin concentration determined by point-of-care device and complete blood count in adult patients with dengue. Wisanuvej K, Boonyawat K, Savetamornkul C, Virapongsiri S, Krongvorakul J, Sungkanuparph S, Phuphuakrat A. PLoS Negl Trop Dis. 2021 Aug 16;15(8):e0009692. doi: 10.1371/journal.pntd.0009692. eCollection 2021 Aug. PMID: 34398882 Free PMC article.

12. Targeting UCHL1 Induces Cell Cycle Arrest in High-Risk Multiple Myeloma with t(4;14). Kamseng P, Siriboonpiputtana T, Puavilai T, Chuncharunee S, Paisooksantivatana K, Chareonsirisuthigul T, Junking M, Chiraphapphaiboon W, Yenchitsomanus PT, Rerkamnuaychoke B. Pathol Oncol Res. 2021 Mar 31;27:606567. doi: 10.3389/pore.2021.606567. eCollection 2021. PMID: 34257568 Free PMC article.

13. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate intensity anticoagulation in critically ill patients. Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid DL, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Righini M, Sanfilippo K, Siegal DM, Skara M, Terrell DR, Touri K, Akl EA, Bou Akl I, Bognanni A, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness KL, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Muti-Schünemann G, Noori A, Philip BA, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Wiercioch W, Mustafa RA, Schunemann HJ. Blood Adv. 2021 Sep 2:bloodadvances.2021005493. doi: 10.1182/bloodadvances.2021005493. Online ahead of print. PMID: 34474482 Free PMC article.

14. MYH9 disorder: Identification and a novel mutation in patients with macrothrombocytopenia. Natesirinilkul R, Sosothikul D, Komwilaisak P, Pongtanakul B, Narkbunnum N, Yudhasompop N, Mekjarusgool P, Niparuck P, Boonyawat K, Kunishima S, Sirachainan N; Thai Macrothrombocytopenia Study Group. Pediatr Blood Cancer. 2021 Jul;68(7):e29055. doi: 10.1002/pbc.29055. Epub 2021 Apr 15. PMID: 33855781

15. Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG). Wanitpongpun C, Utchariyaprasit E, Owattanapanich W, Tantiworawit A, Rattarittamrong E, Niparuck P, Puavilai T, Julamanee J, Saelue P, Chanswangphuwana C, Polprasert C, Nakhakes C, Limvorapitak W, Kanitsap N, Prayongratana K, Sriswasdi C. Clin Lymphoma Myeloma Leuk. 2021 Jul;21(7):e635-e643. doi: 10.1016/j.clml.2021.03.004. Epub 2021 Mar 20. PMID: 33926829 Free article.

16. Reduced-dose direct oral anticoagulants (DOACs) in the extended treatment of venous thromboembolism: A systematic review and meta-analysis-Response to Commentary. Vasanthamohan L, Boonyawat K, Chai-Adisaksopha C, Crowther M. J Thromb Haemost. 2021 Sep;19(9):2359-2360. doi: 10.1111/jth.15427.

2020

1. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE. Weitz JI, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. J Thromb Thrombolysis. 2020 Aug;50(2):267-277. doi: 10.1007/s11239-020-02180-x. PMID: 32583306

2. Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta-analysis. Puavilai T, Thadanipon K, Rattanasiri S, Ingsathit A, McEvoy M, Attia J, Thakkinstian A. Br J Haematol. 2020 Feb;188(3):450-459. doi: 10.1111/bjh.16161. Epub 2019 Aug 18. PMID: 31423574 Free PMC article.

3. Saliva sample as a non-invasive specimen for the diagnosis of coronavirus disease 2019: a cross-sectional study. Pasomsub E, Watcharananan SP, Boonyawat K, Janchompoo P, Wongtabtim G, Suksuwan W, Sungkanuparph S, Phuphuakrat A. Clin Microbiol Infect. 2021 Feb;27(2):285.e1-285.e4. doi: 10.1016/j.cmi.2020.05.001. Epub 2020 May 15. PMID: 32422408 Free PMC article.

4. Novel DDX41 variants in Thai patients with myeloid neoplasms. Polprasert C, Takeda J, Niparuck P, Rattanathammethee T, Pirunsarn A, Suksusut A, Kobbuaklee S, Wudhikarn K, Lawasut P, Kongkiatkamon S, Chuncharunee S, Songserm K, Phowthongkum P, Bunworasate U, Nannya Y, Yoshida K, Makishima H, Ogawa S, Rojnuckarin P. Int J Hematol. 2020 Feb;111(2):241-246. doi: 10.1007/s12185-019-02770-3. Epub 2019 Nov 11. PMID: 31713024

5. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. Bounameaux H, Haas S, Farjat AE, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Schellong S, Mantovani LG, Prandoni P, Kakkar AK. Thromb Res. 2020 Jul;191:103-112. doi: 10.1016/j.thromres.2020.04.036. Epub 2020 Apr 28. PMID: 32422442

6. Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group. Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, Chuncharunee S, Niparuck P, Numbenjapon T, Prayongratana K, Kanitsap N, Wongkhantee S, Makruasi N, Wong P, Norasetthada L, Nawarawong W, Sirijerachai C, Chansung K, Suwanban T, Praditsuktavorn P, Intragumtornchai T; Thai Lymphoma Study Group. J Geriatr Oncol. 2020 Jan;11(1):62-68. doi: 10.1016/j.jgo.2019.03.016. Epub 2019 Mar 30. PMID: 30940492

7. Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease. Goto S, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Weitz JI, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat A, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE Investigators. JAMA Netw Open. 2020 Oct 1;3(10):e2022886. doi: 10.1001/jamanetworkopen.2020.22886. PMID: 33112399 Free PMC article.

8. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Boonyawat K, Chantrathammachart P, Numthavaj P, Nanthatanti N, Phusanti S, Phuphuakrat A, Niparuck P, Angchaisuksiri P. Thromb J. 2020 Nov 23;18(1):34. doi: 10.1186/s12959-020-00248-5. PMID: 33292258 Free PMC article.

9. Genetic Risk Surveillance for Invasive Aspergillosis in Hematology Patients: A Prospective Observational Study. Tanpaibule T, Jinawath N, Taweewongsounton A, Niparuck P, Rotjanapan P. Infect Dis Ther. 2020 Dec;9(4):807-821. doi: 10.1007/s40121-020-00331-4. Epub 2020 Aug 28. PMID: 32860206 Free PMC article.

10. Predicting arterio-venous fistula failure by urea-method derived access blood flow in chronic hemodialysis patients. Lelamali K, Papirachanat P, Puavilai T. J Vasc Access. 2020 Nov;21(6):1011-1016. doi: 10.1177/1129729820920115. Epub 2020 May 11. PMID: 32390506

11. A clinical and histological comparison between acute cutaneous graft-versus-host disease and other maculopapular eruptions following hematopoietic stem cell transplantation: a retrospective cohort. Chanprapaph K, Leerunyakul K, Niparuck P, Rutnin S. Int J Dermatol. 2021 Jan;60(1):60-69. doi: 10.1111/ijd.15186. Epub 2020 Sep 29. PMID: 32989780

12. Etiologies and Treatment Burden in Adult Patients with Pure Red Cell Aplasia: A Single-Center Experience and Review of Literature. Niparuck P, Kanoksil W, Wacharapornin P, Chantrathammachart P, Boongird S. Anemia. 2020 Mar 15;2020:4812759. doi: 10.1155/2020/4812759. eCollection 2020. PMID: 32257434 Free PMC article.

13. Prognostic Value of Concurrent Expression of C-MYC and BCL2 in Intravascular Large B-Cell Lymphoma: A 10-Year Retrospective Study. Boonsakan P, Iamsumang W, Chantrathammachart P, Chayavichitsilp P, Suchonwanit P, Rutnin S. Biomed Res Int. 2020 May 22;2020:1350820. doi: 10.1155/2020/1350820. eCollection 2020. PMID: 32566654 Free PMC article.

14. Left ventricular thrombus and pulmonary embolism: A case series of thrombosis in COVID-19 in Thai patients. Nanthatanti N, Phusanti S, Chantrathammachart P, Thammavaranucupt K, Angchaisuksiri P, Sungkanuparph S. Res Pract Thromb Haemost. 2020 Oct 13;4(7):1224-1229. doi: 10.1002/rth2.12435. eCollection 2020 Oct. PMID: 33134788 Free PMC article.

15. Practical Laboratory Tools for Monitoring of BCR-ABL1 Transcripts and Tyrosine Kinase (TK) Domain Mutations in Chronic Myeloid Leukemia Patients Undergoing TK Inhibitor Therapy: A Single-Center Experience in Thailand. Limsuwanachot N, Kongruang A, Rerkamnuaychoke B, Singdong R, Niparuck P, Jootar S, Siriboonpiputtana T. Asian Pac J Cancer Prev. 2020 Jul 1;21(7):2003-2012. doi: 10.31557/APJCP.2020.21.7.2003. PMID: 32711426 Free PMC article. Clinical Trial.

16. Correction to: Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Boonyawat K, Chantrathammachart P, Numthavaj P, Nanthatanti N, Phusanti S, Phuphuakrat A, Niparuck P, Angchaisuksiri P. Thromb J. 2020 Dec 29;18(1):39. doi: 10.1186/s12959-020-00254-7. PMID: 33372614 Free PMC article. No abstract available.

17. Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group. Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, Niparuck P, Chuncharunee S, Numbenjapon T, Prayongratana K, Kanitsap N, Wongkhantee S, Makruasi N, Wong P, Norasetthada L, Nawarawong W, Sirijerachai C, Chansung K, Suwanban T, Praditsuktavorn P, Intragumtornchai T. Leuk Lymphoma. 2020 Nov;61(11):2614-2621. doi: 10.1080/10428194.2020.1780586. Epub 2020 Jun 23. PMID: 32573294

2019

1. Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry. Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Pieper KS, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Thromb Haemost. 2019 Feb;119(2):319-327. doi: 10.1055/s-0038-1676611. Epub 2018 Dec 28. PMID: 30593086

2. Treatment efficacy for adult persistent immune thrombocytopenia: a systematic review and network meta-analysis. Puavilai T, Thadanipon K, Rattanasiri S, Ingsathit A, McEvoy M, Attia J, Thakkinstian A. Br J Haematol. 2020 Feb;188(3):450-459. doi: 10.1111/bjh.16161. Epub 2019 Aug 18. PMID: 31423574 Free PMC article.

3. Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: phase 2 trial results. Shapiro AD, Angchaisuksiri P, Astermark J, Benson G, Castaman G, Chowdary P, Eichler H, Jiménez-Yuste V, Kavakli K, Matsushita T, Poulsen LH, Wheeler AP, Young G, Zupancic-Salek S, Oldenburg J. Blood. 2019 Nov 28;134(22):1973-1982. doi: 10.1182/blood.2019001542. PMID: 31444162 Free PMC article. Clinical Trial.

4. Novel DDX41 variants in Thai patients with myeloid neoplasms. Polprasert C, Takeda J, Niparuck P, Rattanathammethee T, Pirunsarn A, Suksusut A, Kobbuaklee S, Wudhikarn K, Lawasut P, Kongkiatkamon S, Chuncharunee S, Songserm K, Phowthongkum P, Bunworasate U, Nannya Y, Yoshida K, Makishima H, Ogawa S, Rojnuckarin P. Int J Hematol. 2020 Feb;111(2):241-246. doi: 10.1007/s12185-019-02770-3. Epub 2019 Nov 11. PMID: 31713024

5. Treatment outcome and prognostic factors in PCNSL. Niparuck P, Boonsakan P, Sutthippingkiat T, Pukiat S, Chantrathammachart P, Phusanti S, Boonyawat K, Puavilai T, Angchaisuksiri P, Ungkanont A, Chuncharunee S, Atichartakarn V. Diagn Pathol. 2019 Jun 13;14(1):56. doi: 10.1186/s13000-019-0833-1. PMID: 31189479 Free PMC article.

6. Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group. Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, Chuncharunee S, Niparuck P, Numbenjapon T, Prayongratana K, Kanitsap N, Wongkhantee S, Makruasi N, Wong P, Norasetthada L, Nawarawong W, Sirijerachai C, Chansung K, Suwanban T, Praditsuktavorn P, Intragumtornchai T; Thai Lymphoma Study Group. J Geriatr Oncol. 2020 Jan;11(1):62-68. doi: 10.1016/j.jgo.2019.03.016. Epub 2019 Mar 30. PMID: 30940492

7. Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry. Schellong SM, Goldhaber SZ, Weitz JI, Ageno W, Bounameaux H, Turpie AGG, Angchaisuksiri P, Haas S, Goto S, Zaghdoun A, Farjat A, Nielsen JD, Kayani G, Mantovani LG, Prandoni P, Kakkar AK. Thromb Haemost. 2019 Oct;119(10):1675-1685. doi: 10.1055/s-0039-1693461. Epub 2019 Aug 1. PMID: 31370075 Free article.

8. International Society on Thrombosis and Haemostasis core curriculum project: Core competencies in laboratory thrombosis and hemostasis. Moffat KA, Kiencke V, Blanco AN, McLintock C, Peyvandi F, de Maat MPM, Adams MJ, Angchaisuksiri P, Nair S, Tsuda H, Haddad M, Renné T, Clark RC, Ross MT. J Thromb Haemost. 2019 Nov;17(11):1848-1859. doi: 10.1111/jth.14601. Epub 2019 Sep 5. PMID: 31400072 Free article. Review.

9. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients. Haas S, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Zaghdoun A, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK. J Thromb Haemost. 2019 Oct;17(10):1694-1706. doi: 10.1111/jth.14548. Epub 2019 Jul 23. PMID: 31220403

10. Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry. Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Farjat AE, Zaghdoun A, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Darius H, Kakkar AK. Thromb Haemost. 2019 Aug;119(8):1365-1372. doi: 10.1055/s-0039-1688828. Epub 2019 Jun 10. PMID: 31183844

11. Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia. Niparuck P, Limsuwanachot N, Pukiat S, Chantrathammachart P, Rerkamnuaychoke B, Magmuang S, Phusanti S, Boonyawat K, Puavilai T, Angchaisuksiri P, Ungkanont A, Chuncharunee S. Exp Hematol Oncol. 2019 Jan 30;8:3. doi: 10.1186/s40164-019-0127-z. eCollection 2019. PMID: 30729065 Free PMC article.

12. Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF. Haas S, Camm AJ, Bassand JP, Angchaisuksiri P, Cools F, Corbalan R, Gibbs H, Jacobson B, Koretsune Y, Mantovani LG, Misselwitz F, Panchenko E, Ragy HI, Stepinska J, Turpie AG, Sawhney JP, Steffel J, Lim TW, Pieper KS, Virdone S, Verheugt FW, Kakkar AK; GARFIELD-AF Investigators. Am Heart J. 2019 Jul;213:35-46. doi: 10.1016/j.ahj.2019.03.013. Epub 2019 Apr 11. PMID: 31128503 Free article.

13. Review of disease-related complications and management in adult patients with thalassemia: A multi-center study in Thailand. Chuncharunee S, Teawtrakul N, Siritanaratkul N, Chueamuangphan N. PLoS One. 2019 Mar 20;14(3):e0214148. doi: 10.1371/journal.pone.0214148. eCollection 2019. PMID: 30893381 Free PMC article.

14. Better survivals in adolescent and Young adults, compared to adults with acute lymphoblastic leukemia - A multicenter prospective registry in Thai population.

15. Limvorapitak W, Owattanapanich W, Utchariyaprasit E, Niparuck P, Puavilai T, Tantiworawit A, Rattanathammethee T, Saengboon S, Sriswasdi C, Julamanee J, Saelue P, Polprasert C, Wudhikarn K, Wanitpongpun C, Prayongratana K; Thai Acute Leukemia Working Group. Leuk Res. 2019 Dec;87:106235. doi: 10.1016/j.leukres.2019.106235. Epub 2019 Oct 15. PMID: 31675661

16. Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent β-thalassemia/HbE patients with pulmonary arterial hypertension. Manakeng K, Prasertphol P, Phongpao K, Chuncharunee S, Tanyong D, Worawichawong S, Svasti S, Chaichompoo P. Ann Hematol. 2019 Feb;98(2):281-288. doi: 10.1007/s00277-018-3518-z. Epub 2018 Oct 18. PMID: 30334069 Clinical Trial.

17. Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data. Eichler H, Angchaisuksiri P, Kavakli K, Knoebl P, Windyga J, Jiménez-Yuste V, Harder Delff P, Chowdary P. Haemophilia. 2019 Jan;25(1):60-66. doi: 10.1111/hae.13627. Epub 2018 Nov 8. PMID: 30408848 Free PMC article. Clinical Trial.

18. Management and 1-Year Outcomes of Patients With Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: Results From the Prospective GARFIELD - AF Registry. Goto S, Angchaisuksiri P, Bassand JP, Camm AJ, Dominguez H, Illingworth L, Gibbs H, Goldhaber SZ, Goto S, Jing ZC, Haas S, Kayani G, Koretsune Y, Lim TW, Oh S, Sawhney JPS, Turpie AGG, van Eickels M, Verheugt FWA, Kakkar AK; GARFIELD‐AF Investigators. J Am Heart Assoc. 2019 Feb 5;8(3):e010510. doi: 10.1161/JAHA.118.010510. PMID: 30717616 Free PMC article.

19. Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma. Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Ekwattanakit S, Khuhapinant A, Niparuck P, Chuncharunee S, Numbenjapon T, Prayongratana K, Kanitsap N, Wongkhantee S, Makruasri N, Wong P, Norasetthada L, Nawarawong W, Sirijerachai C, Chansung K, Suwanban T, Praditsuktavorn P, Intragumtornchai T; Thai Lymphoma Study Group. Hematol Oncol. 2019 Dec;37(5):578-585. doi: 10.1002/hon.2687. Epub 2019 Nov 12. PMID: 31702065

20. Oral anticoagulant-associated bleeding requiring hospitalization in Thai patients: Incidences, risk factors, and outcomes. Boonyawat K, Kunakorntham P, Angchaisuksiri P. Thromb Res. 2019 Nov;183:33-35. doi: 10.1016/j.thromres.2019.09.004. Epub 2019 Sep 5. PMID: 31536873 No abstract available.

21. First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012. Bacigalupo A, Oneto R, Schrezenmeier H, Hochsmann B, Dufour C, Kojima S, Zhu X, Chen X, Issaragrisil S, Chuncharunee S, Chul Jeong D, Giammarco S, Teresa Van Lint M, Zheng Y, Vallejo C. Am J Hematol. 2019 Jan;94(1):165. doi: 10.1002/ajh.25138. Epub 2018 Jul 23.

2018

1. Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry. Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Pieper KS, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Thromb Haemost. 2019 Feb;119(2):319-327. doi: 10.1055/s-0038-1676611. Epub 2018 Dec 28. PMID: 30593086

2. Global public awareness about atrial fibrillation. Wendelboe AM, Raskob GE, Angchaisuksiri P, Blanco AN, Büller H, Ddungu H, Dvorak JD, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, McLintock C, Urano T, Weitz JI. Res Pract Thromb Haemost. 2017 Oct 25;2(1):49-57. doi: 10.1002/rth2.12051. eCollection 2018 Jan. PMID: 30046706 Free PMC article.

3. The Frequency of SF3B1 Mutations in Thai Patients with Myelodysplastic Syndrome. Rujirachaivej P, Siriboonpiputtana T, Rerkamnuaychoke B, Magmuang S, Chareonsirisuthigul T, Boonsakan P, Petvises S, Sirirat T, Niparuck P, Chuncharunee S. Asian Pac J Cancer Prev. 2018 Jul 27;19(7):1825-1831. doi: 10.22034/APJCP.2018.19.7.1825. PMID: 30049194 Free PMC article.

4. Elevated levels of platelet- and red cell-derived extracellular vesicles in transfusion-dependent β-thalassemia/HbE patients with pulmonary arterial hypertension. Manakeng K, Prasertphol P, Phongpao K, Chuncharunee S, Tanyong D, Worawichawong S, Svasti S, Chaichompoo P. Ann Hematol. 2019 Feb;98(2):281-288. doi: 10.1007/s00277-018-3518-z. Epub 2018 Oct 18. PMID: 30334069 Clinical Trial.

5. Reduced-dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta-analysis. Vasanthamohan L, Boonyawat K, Chai-Adisaksopha C, Crowther M. J Thromb Haemost. 2018 Jul;16(7):1288-1295. doi: 10.1111/jth.14156. Epub 2018 Jun 17. PMID: 29772108 Free article.

6. A randomized trial of safety, pharmacokinetics and pharmacodynamics of concizumab in people with hemophilia A. Eichler H, Angchaisuksiri P, Kavakli K, Knoebl P, Windyga J, Jiménez-Yuste V, Hyseni A, Friedrich U, Chowdary P. J Thromb Haemost. 2018 Nov;16(11):2184-2195. doi: 10.1111/jth.14272. Epub 2018 Sep 30. PMID: 30137664 Free article. Clinical Trial.

7. Concizumab restores thrombin generation potential in patients with haemophilia: Pharmacokinetic/pharmacodynamic modelling results of concizumab phase 1/1b data. Eichler H, Angchaisuksiri P, Kavakli K, Knoebl P, Windyga J, Jiménez-Yuste V, Harder Delff P, Chowdary P. Haemophilia. 2019 Jan;25(1):60-66. doi: 10.1111/hae.13627. Epub 2018 Nov 8. PMID: 30408848 Free PMC article. Clinical Trial.

8. Haemophilia clinical care and research needs: Assessing priorities. Chowdary P, Angchaisuksiri P, Dimsits J, Iorio A, Kavakli K, Lentz SR, Mahlangu J, McCarthy A, Kessler C. Haemophilia. 2018 Jul;24(4):e270-e273. doi: 10.1111/hae.13544. Epub 2018 Jul 13. PMID: 30004622 No abstract available.

9. Deferiprone as adjunctive treatment for patients with invasive mucormycosis: A retrospective case series. Chitasombat MN, Niparuck P. Infect Dis Rep. 2018 Sep 25;10(2):7765. doi: 10.4081/idr.2018.7765. eCollection 2018 Sep 5. PMID: 30344970 Free PMC article.

10. Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry. Verheugt FWA, Gao H, Al Mahmeed W, Ambrosio G, Angchaisuksiri P, Atar D, Bassand JP, Camm AJ, Cools F, Eikelboom J, Kayani G, Lim TW, Misselwitz F, Pieper KS, van Eickels M, Kakkar AK; GARFIELD-AF Investigators. Eur Heart J. 2018 Feb 7;39(6):464-473. doi: 10.1093/eurheartj/ehx730. PMID: 29281086

11. First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012. Bacigalupo A, Oneto R, Schrezenmeier H, Hochsmann B, Dufour C, Kojima S, Zhu X, Chen X, Issaragrisil S, Chuncharunee S, Jeong DC, Giammarco S, Van Lint MT, Zheng Y, Vallejo C. Am J Hematol. 2018 May;93(5):643-648. doi: 10.1002/ajh.25081. Epub 2018 Mar 23. PMID: 29498107 Free PMC article.

12. Improved Survival of Elderly-fit Patients With Acute Myeloid Leukemia Requiring Intensive Therapy: 3-Year Multicenter Analysis From TALWG. Owattanapanich W, Utchariyaprasit E, Tantiworawit A, Rattarittamrong E, Niparuck P, Puavilai T, Julamanee J, Saelue P, Chanswangphuwana C, Polprasert C, Limvorapitak W, Kanitsap N, Wanitpongpun C, Nakhakes C, Sriswasdi C, Prayongratana K. Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):e509-e514. doi: 10.1016/j.clml.2018.08.002. Epub 2018 Aug 8. PMID: 30213720

13. Atypical central retinal artery occlusion as the first presentation of POEMS syndrome: a case report. Jindahra P, Dejthevaporn C, Niparuck P, Waisayarat J, Cheecharoen P, Threetong T, Petpiroon P, Sujirakul T, Poonyathalang A, Vanikieti K. BMC Neurol. 2018 May 8;18(1):64. doi: 10.1186/s12883-018-1071-y. PMID: 29739345 Free PMC article.

14. Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand. Intragumtornchai T, Bunworasate U, Wudhikarn K, Lekhakula A, Julamanee J, Chansung K, Sirijerachai C, Norasetthada L, Nawarawong W, Khuhapinant A, Siritanaratanakul N, Numbenjapon T, Prayongratana K, Chuncharunee S, Niparuck P, Suwanban T, Kanitsap N, Wongkhantee S, Pornvipavee R, Wong P, Makruasi N, Wannakrairot P, Assanasen T, Sukpanichnant S, Boonsakan P, Kanoksil W, Ya-In C, Kayasut K, Mitranun W, Warnnissorn N. Hematol Oncol. 2018 Feb;36(1):28-36. doi: 10.1002/hon.2392. Epub 2017 Mar 23. PMID: 28332735

15. Inhaled nebulized sodium nitrite decreases pulmonary artery pressure in β-thalassemia patients with pulmonary hypertension. Yingchoncharoen T, Rakyhao T, Chuncharunee S, Sritara P, Pienvichit P, Paiboonsukwong K, Sathavorasmith P, Sirirat K, Sriwantana T, Srihirun S, Sibmooh N. Nitric Oxide. 2018 Jun 1;76:174-178. doi: 10.1016/j.niox.2017.09.010. Epub 2017 Sep 28. PMID: 28964835 Clinical Trial.

16. Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy. Walewski J, Hellmann A, Siritanaratkul N, Ozsan GH, Ozcan M, Chuncharunee S, Goh AS, Jurczak W, Koren J, Paszkiewicz-Kozik E, Wang B, Singh S, Huebner D, Engert A, von Tresckow B. Br J Haematol. 2018 Nov;183(3):400-410. doi: 10.1111/bjh.15539. Epub 2018 Aug 30. PMID: 30168134 Clinical Trial.

17. Unusual manifestation of vitamin A deficiency presenting with generalized xerosis without night blindness. Phanachet P, Shantavasinkul PC, Chantrathammachart P, Rattanakaemakorn P, Jayanama K, Komindr S, Warodomwichit D. Clin Case Rep. 2018 Mar 13;6(5):878-882. doi: 10.1002/ccr3.1475. eCollection 2018 May. PMID: 29744078 Free PMC article.

18. First line treatment of aplastic anemia with thymoglobuline in Europe and Asia: Outcome of 955 patients treated 2001-2012. Bacigalupo A, Oneto R, Schrezenmeier H, Hochsmann B, Dufour C, Kojima S, Zhu X, Chen X, Issaragrisil S, Chuncharunee S, Chul Jeong D, Giammarco S, Teresa Van Lint M, Zheng Y, Vallejo C. Am J Hematol. 2019 Jan;94(1):165. doi: 10.1002/ajh.25138. Epub 2018 Jul 23.

2017

1. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism. Liew NC, Alemany GV, Angchaisuksiri P, Bang SM, Choi G, DE Silva DA, Hong JM, Lee L, Li YJ, Rajamoney GN, Suviraj J, Tan TC, Tse E, Teo LT, Visperas J, Wong RS, Lee LH. Int Angiol. 2017 Feb;36(1):1-20. doi: 10.23736/S0392-9590.16.03765-2. Epub 2016 Sep 8. PMID: 27606807 Free article.

2. Global public awareness about atrial fibrillation. Wendelboe AM, Raskob GE, Angchaisuksiri P, Blanco AN, Büller H, Ddungu H, Dvorak JD, Hunt BJ, Hylek EM, Kakkar A, Konstantinides SV, McCumber M, McLintock C, Urano T, Weitz JI. Res Pract Thromb Haemost. 2017 Oct 25;2(1):49-57. doi: 10.1002/rth2.12051. eCollection 2018 Jan. PMID: 30046706 Free PMC article.

3. Clinical and hematological relevance of JAK2 V617F and CALR mutations in BCR-ABL-negative ET patients. Limsuwanachot N, Rerkamnuaychoke B, Chuncharunee S, Pauwilai T, Singdong R, Rujirachaivej P, Chareonsirisuthigul T, Siriboonpiputtana T. Hematology. 2017 Dec;22(10):599-606. doi: 10.1080/10245332.2017.1312736. Epub 2017 Apr 13. PMID: 28406068

4. Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta-analysis. Boonyawat K, Caron F, Li A, Chai-Adisaksopha C, Lim W, Iorio A, Lopes RD, Garcia D, Crowther MA. J Thromb Haemost. 2017 Jul;15(7):1322-1333. doi: 10.1111/jth.13701. Epub 2017 May 9. PMID: 28407368 Free article. Review.

5. How I treat heavy menstrual bleeding associated with anticoagulants. Boonyawat K, O'Brien SH, Bates SM. Blood. 2017 Dec 14;130(24):2603-2609. doi: 10.1182/blood-2017-07-797423. Epub 2017 Nov 1. PMID: 29092828 Free article.

6. Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry. Wudhikarn K, Bunworasate U, Julamanee J, Lekhakula A, Chuncharunee S, Niparuck P, Ekwattanakit S, Khuhapinant A, Norasetthada L, Nawarawong W, Makruasi N, Kanitsap N, Sirijerachai C, Chansung K, Wong P, Numbenjapon T, Prayongratana K, Suwanban T, Wongkhantee S, Praditsuktavorn P, Intragumtornchai T; Thai Lymphoma Study Group. Ann Hematol. 2017 Jan;96(1):57-64. doi: 10.1007/s00277-016-2848-y. Epub 2016 Oct 18. PMID: 27752821

7. Mutation Analysis of Isocitrate Dehydrogenase (IDH1/2) and DNA Methyltransferase 3A (DNMT3A) in Thai Patients with Newly Diagnosed Acute Myeloid Leukemia. Sirirat T, Chuncharunee S, Nipaluk P, Siriboonpiputtana T, Chareonsirisuthigul T, Limsuwannachot N, Rerkamnuaychoke B. Asian Pac J Cancer Prev. 2017 Feb 1;18(2):413-420. doi: 10.22034/APJCP.2017.18.2.413. PMID: 28345823 Free PMC article.

8. Low oxygen saturation and severe anemia in compound heterozygous Hb Louisville [β42(CD1)Phe→Leu] and Hb La Desirade [β129(H7)Ala→Val]. Kamseng P, Trakulsrichai S, Trachoo O, Yimniam W, Panthan B, Jittorntam P, Niparuck P, Sanguanwit P, Wananukul W, Jindadamrongwech S. Hematology. 2017 Mar;22(2):114-118. doi: 10.1080/10245332.2016.1231989. Epub 2016 Sep 27. PMID: 27670359

9. Non-Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand. Intragumtornchai T, Bunworasate U, Wudhikarn K, Lekhakula A, Julamanee J, Chansung K, Sirijerachai C, Norasetthada L, Nawarawong W, Khuhapinant A, Siritanaratanakul N, Numbenjapon T, Prayongratana K, Chuncharunee S, Niparuck P, Suwanban T, Kanitsap N, Wongkhantee S, Pornvipavee R, Wong P, Makruasi N, Wannakrairot P, Assanasen T, Sukpanichnant S, Boonsakan P, Kanoksil W, Ya-In C, Kayasut K, Mitranun W, Warnnissorn N. Hematol Oncol. 2018 Feb;36(1):28-36. doi: 10.1002/hon.2392. Epub 2017 Mar 23. PMID: 28332735

10. Inhaled nebulized sodium nitrite decreases pulmonary artery pressure in β-thalassemia patients with pulmonary hypertension. Yingchoncharoen T, Rakyhao T, Chuncharunee S, Sritara P, Pienvichit P, Paiboonsukwong K, Sathavorasmith P, Sirirat K, Sriwantana T, Srihirun S, Sibmooh N. Nitric Oxide. 2018 Jun 1;76:174-178. doi: 10.1016/j.niox.2017.09.010. Epub 2017 Sep 28. PMID: 28964835 Clinical Trial.

11. Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant. Issaragrisil S, Cheng-Hwai T, Bunworasate U, Su-Peng Y, Hung LY, Tee GY, Wahid SF, Chin NS, Puavilai T, Gin GG, Piu KL, Wen-Li H, Tsai-Yun C, Numbenjapon T. Bone Marrow Transplant. 2017 Feb;52(2):299-300. doi: 10.1038/bmt.2016.245. Epub 2016 Nov 14. PMID: 27841857 Free PMC article. Clinical Trial. No abstract available.

12. Management of Venous Thromboembolism in Patients with Hereditary Antithrombin Deficiency and Pregnancy: Case Report and Review of the Literature. Refaei M, Xing L, Lim W, Crowther M, Boonyawat K. Case Rep Hematol. 2017;2017:9261351. doi: 10.1155/2017/9261351. Epub 2017 Jan 10.

2016

1. Characterization and Prognosis Significance of JAK2 (V617F), MPL, and CALR Mutations in Philadelphia-Negative Myeloproliferative Neoplasms. Singdong R, Siriboonpiputtana T, Chareonsirisuthigul T, Kongruang A, Limsuwanachot N, Sirirat T, Chuncharunee S, Rerkamnuaychoke B. Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4647-4653.
2. Efficacy of rabbit antithymocyte globulin as first-line treatment of severe aplastic anemia: an Asian multicenter retrospective study. Chuncharunee S, Wong R, Rojnuckarin P, Chang CS, Chang KM, Lu MY, Hwang WL, Koh LP, Chen TY, Leung AY, Norasetthada L, Wang SC, Chang MC, Wu KH, Issaragrisil S. Int J Hematol. 2016 Oct;104(4):454-61.
3. Multiplex RT-PCR Assay for Detection of Common Fusion Transcripts in Acute Lymphoblastic Leukemia and Chronic Myeloid Leukemia Cases. Limsuwanachot N, Siriboonpiputtana T, Karntisawiwat K, Chareonsirisuthigul T, Chuncharunee S, Rerkamnuaychoke B. Asian Pac J Cancer Prev. 2016;17(2):677-84.
4. Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors. Anurathapan U, Hongeng S, Pakakasama S, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Rujkijyanont P, Meekaewkunchorn A, Lektrakul Y, Iamsirirak P, Surapolchai P, Satayasai W, Sirireung S, Sruamsiri R, Wahidiyat PA, Ungkanont A, Issaragrisil S, Andersson BS. Bone Marrow Transplant. 2016 Jun;51(6):813-8.
5. Quality of Vitamin K Antagonist Control and 1-Year Outcomes in Patients with Atrial Fibrillation: A Global Perspective from the GARFIELD-AF Registry. Haas S, Ten Cate H, Accetta G, Angchaisuksiri P, Bassand JP, Camm AJ, Corbalan R, Darius H, Fitzmaurice DA, Goldhaber SZ, Goto S, Jacobson B, Kayani G, Mantovani LG, Misselwitz F, Pieper K, Schellong SM, Stepinska J, Turpie AG, van Eickels M, Kakkar AK; GARFIELD-AF Investigators. PLoS One. 2016 Oct 28;11(10):e0164076.
6. Cancer-associated thrombosis in Asia. Angchaisuksiri P. Thromb J. 2016 Oct 4;14(Suppl 1):26. Review.
7. Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design. Weitz JI, Haas S, Ageno W, Angchaisuksiri P, Bounameaux H, Nielsen JD, Goldhaber SZ, Goto S, Kayani G, Mantovani L, Prandoni P, Schellong S, Turpie AG, Kakkar AK. Thromb Haemost. 2016 Nov 30;116(6):1172-1179.
8. Asian venous thromboembolism guidelines: updated recommendations for the prevention of venous thromboembolism. Liew NC, Alemany GV, Angchaisuksiri P, Bang SM, Choi G, DE Silva DA, Hong JM, Lee L, Li YJ, Rajamoney GN, Suviraj J, Tan TC, Tse E, Teo LT, Visperas J, Wong RS, Lee LH. Int Angiol. 2017 Feb;36(1):1-20.
9. Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry. Oh S, Goto S, Accetta G, Angchaisuksiri P, Camm AJ, Cools F, Haas S, Kayani G, Koretsune Y, Lim TW, Misselwitz F, van Eickels M, Kakkar AK; GARFIELD-AF Investigators. Int J Cardiol. 2016 Nov 15;223:543-547.
10. Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial. Raskob GE, van Es N, Segers A, Angchaisuksiri P, Oh D, Boda Z, Lyons RM, Meijer K, Gudz I, Weitz JI, Zhang G, Lanz H, Mercuri MF, Büller HR; Hokusai-VTE investigators. Lancet Haematol. 2016 Aug;3(8):e379-87.
11. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists. Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, Pieper K, Ten Cate H, Turpie AG, Kakkar AK; GARFIELD-AF Investigators. Br J Haematol. 2016 Aug;174(4):610-23.
12. International Society on Thrombosis and Haemostasis core curriculum project: core competencies in clinical thrombosis and hemostasis. McLintock C, Pabinger I, Bauer KA, Laffan M, Angchaisuksiri P, Rezende SM, Middeldorp S, Ross M. J Thromb Haemost. 2016 Jan;14(1):3-27.
13. Cyclophosphamide vs salvage chemotherapy plus G-CSF as chemo-mobilization in Asian patients undergoing autologous hematopoietic stem cell transplant. Issaragrisil S, Cheng-Hwai T, Bunworasate U, Su-Peng Y, Hung LY, Tee GY, Wahid SF, Chin NS, Puavilai T, Gin GG, Piu KL, Wen-Li H, Tsai-Yun C, Numbenjapon T. Bone Marrow Transplant. 2016 Nov 14.
14. Low oxygen saturation and severe anemia in compound heterozygous Hb Louisville [β42(CD1)Phe→Leu] and Hb La Desirade [β129(H7)Ala→Val]. Kamseng P, Trakulsrichai S, Trachoo O, Yimniam W, Panthan B, Jittorntam P, Niparuck P, Sanguanwit P, Wananukul W, Jindadamrongwech S. Hematology. 2016 Sep 27:1-5.
15. Thrombin-independent contribution of tissue factor to inflammation and cardiac hypertrophy in a mouse model of sickle cell disease. Sparkenbaugh EM, Chantrathammachart P, Chandarajoti K, Mackman N, Key NS, Pawlinski R. Blood. 2016 Mar 10;127(10):1371-3.
16. Alveolar Soft Part Sarcoma of Urinary Bladder Occurring as a Second Primary Malignancy: A Case Report and Literature Review. Usawachintachit M, Sitthideatphaiboon P, Thanakit V, Pukiat S, Panumatrassamee K, Opanuraks J, Santi-Ngamkun A. Case Rep Urol. 2016;2016:4746061.
17. Measurement of Dabigatran Drug Levels to Manage Patients Taking Interacting Drugs: A Case Report. Laureano M, Crowther M, Eikelboom J, Boonyawat K. Am J Med. 2016 Oct;129(10):e247-8.
18. The effect of low-dose oral vitamin K supplementation on INR stability in patients receiving warfarin. A randomised trial. Boonyawat K, Wang L, Lazo-Langner A, Kovacs MJ, Yeo E, Schnurr T, Schulman S, Crowther MA. Thromb Haemost. 2016 Aug 30;116(3):480-5.

2015

1. Platelet hyperactivity in thalassemia patients with elevated tricuspid regurgitant velocity and the association with hemolysis. Srihirun S, Tanjararak N, Chuncharunee S, Sritara P, Kaewvichit R, Fucharoen S, Pattanapanyasat K, Sibmooh N. Thromb Res. 2015 Jan;135(1):121-6.
2. A risk score for predicting pulmonary hypertension in patients with non-transfusion-dependent thalassemia in northeastern Thailand: The E-SAAN score. Teawtrakul N, Pussadhamma B, Ungprasert P, Prayalaw P, Fucharoen S, Jetsrisuparb A, Pongudom S, Sirijerachai C, Chansung K, Wanitpongpun C, Thongbuaban S, Thinkhamrop B, Chuncharunee S. Hematology. 2015 Aug;20(7):416-21.
3. Defining serum ferritin thresholds to predict clinically relevant liver iron concentrations for guiding deferasirox therapy when MRI is unavailable in patients with non-transfusion-dependent thalassaemia. Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Origa R, Karakas Z, Habr D, Zhu Z, Cappellini MD.Br J Haematol. 2015 Jan;168(2):284-90.
4. The use of hematocrit level for predicting the efficiency of peripheral blood CD34(+) cell collection after G-CSF Mobilization in Healthy Donors. Pornprasertsud N, Niparuck P, Kidkarn R, Puavilai T, Sirachainan N, Pakakasama S, Hongeng S, Jootar S, Ungkanont A. J Clin Apher. 2015 Dec;30(6):329-34.
5. Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity. Mahlangu JN, Weldingh KN, Lentz SR, Kaicker S, Karim FA, Matsushita T, Recht M, Tomczak W, Windyga J, Ehrenforth S, Knobe K; adept™2 Investigators. J Thromb Haemost. 2015 Nov;13(11):1989-98.
6. Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation. Lip GY, Rushton-Smith SK, Goldhaber SZ, Fitzmaurice DA, Mantovani LG, Goto S, Haas S, Bassand JP, Camm AJ, Ambrosio G, Janský P, Al Mahmeed W, Oh S, van Eickels M, Raatikainen P, Steffel J, Oto A, Kayani G, Accetta G, Kakkar AK; GARFIELD-AF Investigators. Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S12-20.
7. Safety and pharmacokinetics of anti-TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial. Chowdary P, Lethagen S, Friedrich U, Brand B, Hay C, Abdul Karim F, Klamroth R, Knoebl P, Laffan M, Mahlangu J, Miesbach W, Dalsgaard Nielsen J, Martín-Salces M, Angchaisuksiri P. J Thromb Haemost. 2015 May;13(5):743-54.
8. Excess of heme induces tissue factor-dependent activation of coagulation in mice. Sparkenbaugh EM, Chantrathammachart P, Wang S, Jonas W, Kirchhofer D, Gailani D, Gruber A, Kasthuri R, Key NS, Mackman N, Pawlinski R. Haematologica. 2015 Mar;100(3):308-14.
9. Hemodialysis for the treatment of dabigatran-associated bleeding: a case report and systematic review. Chai-Adisaksopha C, Hillis C, Lim W, Boonyawat K, Moffat K, Crowther M. J Thromb Haemost. 2015 Oct;13(10):1790-8.
10. Aspirin in secondary prevention of recurrent venous thromboembolism. Boonyawat K, Crowther MA. J Thromb Thrombolysis. 2015 Apr;39(3):392-4.
11. Venous thromboembolism prophylaxis in critically ill patients. Boonyawat K, Crowther MA. Semin Thromb Hemost. 2015 Feb;41(1):68-74.

2014

1. Effect of acetylsalicylic acid on thalassemia with pulmonary arterial hypertension. Chueamuangphan N, Wongtheptian W, Patumanond J, Sukonthasarn A, Chuncharunee S, Tawichasri C, Nawarawong W.Int J Gen Med. 2014 Dec 3; 7:525-9.
2. Implication of globin gene expression, hemoglobin F and hemoglobin E levels on β-thalassemia/Hb E disease severity. Siriworadechkul S, Jindadamrongwech S, Chuncharunee S, Aupparakkitanon S. Ann Clin Lab Sci. 2014 Fall;44(4):437-42.
3. Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial. San-Miguel JF, Hungria VT, Yoon SS, Beksac M, Dimopoulos MA, Elghandour A, Jedrzejczak WW, Günther A, Nakorn TN, Siritanaratkul N, Corradini P, Chuncharunee S, Lee JJ, Schlossman RL, Shelekhova T, Yong K, Tan D, Numbenjapon T, Cavenagh JD, Hou J, LeBlanc R, Nahi H, Qiu L, Salwender H, Pulini S, Moreau P, Warzocha K, White D, Bladé J, Chen W, de la Rubia J, Gimsing P, Lonial S, Kaufman JL, Ocio EM, Veskovski L, Sohn SK, Wang MC, Lee JH, Einsele H, Sopala M, Corrado C, Bengoudifa BR, Binlich F, Richardson PG. Lancet Oncol. 2014 Oct;15(11):1195-206.
4. Benefits of chronic blood transfusion in hemoglobin E/β thalassemia with pulmonary arterial hypertension. Chueamuangphan N, Patumanond J, Wongtheptien W, Nawarawong W, Sukonthasarn A, Chuncharunee S, Tawichasri C. Int J Gen Med. 2014 Aug 19; 7:411-6.
5. Intravascular hemolysis, vascular endothelial cell activation and thrombophilia in splenectomized patients with hemoglobin E/β-thalassemia disease. Atichartakarn V, Chuncharunee S, Archararit N, Udomsubpayakul U, Aryurachai K. Acta Haematol. 2014;132(1):100-7.
6. Approaching low liver iron burden in chelated patients with non-transfusion-dependent thalassemia: the safety profile of deferasirox. Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Origa R, Karakas Z, Habr D, Zhu Z, Cappellini MD. Eur J Haematol. 2014 Jun;92(6):521-6.
7. Effect of genotype on pulmonary hypertension risk in patients with thalassemia. Teawtrakul N, Ungprasert P, Pussadhamma B, Prayalaw P, Fucharoen S, Jetsrisuparb A, Pongudom S, Sirijerachai C, Chansung K, Wanitpongpun C, Chuncharunee S. Eur J Haematol. 2014;92(5):429-34.
8. Prevalence and risk factors for pulmonary hypertension in patients with hemoglobin E/β-thalassemia disease. Atichartakarn V, Chuncharunee S, Archararit N, Udomsubpayakul U, Lee R, Tunhasiriwet A, Aryurachai K. Eur J Haematol. 2014 Apr;92(4):346-53.
9. Outcomes of thalassemia patients undergoing hematopoietic stem cell transplantation by using a standard myeloablative versus a novel reduced-toxicity conditioning regimen according to a new risk stratification. Anurathapan U, Pakakasama S, Mekjaruskul P, Sirachainan N, Songdej D, Chuansumrit A, Charoenkwan P, Jetsrisuparb A, Sanpakit K, Pongtanakul B, Rujkijyanont P, Meekaewkunchorn A, Sruamsiri R, Ungkanont A, Issaragrisil S, Andersson BS, Hongeng S. Biol Blood Marrow Transplant. 2014 Dec;20(12):2066-71.
10. Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trial. Collins PW, Young G, Knobe K, Karim FA, Angchaisuksiri P, Banner C, Gürsel T, Mahlangu J, Matsushita T, Mauser-Bunschoten EP, Oldenburg J, Walsh CE, Negrier C; paradigm 2 Investigators. Blood. 2014 Dec 18;124(26):3880-6.
11. Low prevalence of heparin-induced thrombocytopenia after cardiac surgery in Thai patients. Boonyawat K, Angchaisuksiri P, Aryurachai K, Chaiyaroj S, Ahmadi Z, Chong BH. Thromb Res. 2014 Nov;134(5):957-62.
12. Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa. Lentz SR, Ehrenforth S, Karim FA, Matsushita T, Weldingh KN, Windyga J, Mahlangu JN; adept™2 investigators. J Thromb Haemost. 2014 Aug;12(8):1244-53.
13. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease. Sparkenbaugh EM, Chantrathammachart P, Mickelson J, van Ryn J, Hebbel RP, Monroe DM, Mackman N, Key NS, Pawlinski R. Blood. 2014 Mar 13;123(11):1747-56.
14. Hydroxyurea and colonic ulcers: a case report. Boonyawat K, Wongwaisayawan S, Nitiyanant P, Atichartakarn V. BMC Gastroenterol. 2014 Jul 31;14:134.

2013

1. Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study. Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhu Z, Cappellini MD. Ann Hematol. 2013 Nov; 92(11):1485-93.
2. Pulmonary artery pressure correlates directly with spleen volume in non-splenectomized hemoglobin E/β-thalassemia patients. Atichartakarn V, Chuncharunee S, Yamwong S, Yingchoncharoen T, Jongjirasiri S, Archararit N, Udomsubpayakul U. Acta Haematol. 2013; 130(3):172-5.
3. Deferasirox demonstrates a dose-dependent reduction in liver iron concentration and consistent efficacy across subgroups of non-transfusion-dependent thalassemia patients. Taher AT, Porter JB, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Habr D, Ros J, Zhang Y, Cappellini MD. Am J Hematol. 2013 Jun; 88 (6):503-6.
4. Unrecognized vertebral fractures in adolescents and young adults with thalassemia syndromes. Engkakul P, Mahachoklertwattana P, Jaovisidha S, Chuansumrit A, Poomthavorn P, Chitrapazt N, Chuncharunee S. J Pediatr Hematol Oncol. 2013 Apr; 35 (3):212-7.
5. Correction of coagulation and inflammation activation by chronic blood transfusion in an asplenic patient with haemoglobin E/β-thalassaemia and pulmonary arterial hypertension. Chuncharunee S, Atichartakarn V, Archararit N, Aryurachai K. Transfus Med. 2013 Aug; 23 (4):276-8.
6. Inferior progression-free survival for Thai patients with diffuse large B-cell lymphoma treated under Universal Coverage Scheme: the impact of rituximab inaccessability. Intragumtornchai T, Bunworasate U, Siritanaratkul N, Khuhapinant A, Nawarawong W, Norasetthada L, Lekhakula A, Rujirojindakul P, Sirijerachai C, Chansung K, Suwanban T, Chuncharunee S, Niparuck P, Wongkhantee S, Mongkonsritragoon W, Numbenjapon T. Leuk Lymphoma. 2013 Jan; 54 (1):83-9.
7. Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia. Cilloni D, Carturan S, Bracco E, Campia V, Rosso V, Torti D, Calabrese C, Gaidano V, Niparuck P, Favole A, Signorino E, Iacobucci I, Morano A, De Luca L, Musto P, Frassoni F, Saglio G. Leuk Res. 2013 Feb 12.
8. High-value, cost-conscious care. Atichartakarn V. Ann Intern Med. 2013 Jan 15; 158(2):143.
9. Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease control. Anurathapan U, Pakakasama S, Rujkijyanont P, Sirachainan N, Songdej D, Chuansumrit A, Sirireung S, Charoenkwan P, Jetsrisuparb A, Issaragrisil S, Ungkanont A, Sruamsiri R, Srisala S, Andersson BS, Hongeng S. Biol Blood Marrow Transplant. 2013 Aug;19(8):1259-62.
10. Tropical hemostasis/thrombosis. Angchaisuksiri P, Chuansumrit A. Thromb Res. 2013;132(6):635-6.
11. Coagulopathy in malaria. Angchaisuksiri P. Thromb Res. 2014 Jan;133(1):5-9.
12. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. Hokusai-VTE Investigators., Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P. N Engl J Med. 2013 Oct 10;369(15):1406-15.
13. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Le Cam-Duchez V, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S. Eur J Epidemiol. 2013 Aug;28(8):621-47.
14. Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. Schulman S, Kearon C, Kakkar AK, Schellong S, Eriksson H, Baanstra D, Kvamme AM, Friedman J, Mismetti P, Goldhaber SZ; RE-MEDY Trial Investigators.; RE-SONATE Trial Investigators. N Engl J Med. 2013 Feb 21;368(8):709-18.
15. Aberrant activation of ROS1 represents a new molecular defect in chronic myelomonocytic leukemia. Cilloni D, Carturan S, Bracco E, Campia V, Rosso V, Torti D, Calabrese C, Gaidano V, Niparuck P, Favole A, Signorino E, Iacobucci I, Morano A, De Luca L, Musto P, Frassoni F, Saglio G. Leuk Res. 2013 May;37(5):520-30.

2012

1. Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study.Taher AT, Porter J, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Ros J, Zhang Y, Habr D, Cappellini MD. Blood. 2012 Aug 2; 120(5): 970-7.
2. Nondeletional Hb Queens Park [α32(B13)Met→Lys]/Hb H (β4) disease. Sroymora S, Jindadamrongwech S, Butthep P, Chuncharunee S. Hemoglobin. 2012; 36(3): 293-8.
3. Clinical indicators for pulmonary arterial hypertension in thalassemia. Chueamuangphan N, Wongtheptien W, Nawarawong W, Sukornthasarn A, Chuncharunee S, Tawichasri C, Patumanond J. J Med Assoc Thai. 2012 Jan; 95(1): 16-21.
4. A rare Hb H disease due to the - -(SEA) and 16.6 kb α-thalassemia-2 deletions. Sroymora S, Jindadamrongwech S, Butthep P, Chuncharunee S. Hemoglobin. 2012; 36(2):200-4.
5. Rechallenge with intravenous recombinant human erythropoietin can be successful following the treatment of anti-recombinant erythropoietin associated pure red cell aplasia. Praditpornsilpa K, Tiranathanakul K, Jootar S, Tungsanga K, Eiam-Ong S. Clin Nephrol. 2012 Oct 30.
6. Depletion of alloreactive T cells for tolerance induction in a recipient of kidney and hematopoietic stem cell transplantations. Tangnararatchakit K, Tirapanich W, Anurathapan U, Tapaneya-Olarn W, Pakakasama S, Jootar S, Slavin S, Hongeng S. Pediatr Transplant. 2012 Dec; 16(8):E342-7.
7. CML treatment in Asia-Pacific region. Jootar S. Hematology. 2012 Apr;17 Suppl 1:S72-4.
8. Extranodal NK/T-cell lymphoma, nasal type, includes cases of natural killer cell and αβ, γδ, and αβ/γδ T-cell origin: a comprehensive clinicopathologic and phenotypic study. Pongpruttipan T, Sukpanichnant S, Assanasen T, Wannakrairot P, Boonsakan P, Kanoksil W, Kayasut K, Mitarnun W, Khuhapinant A, Bunworasate U, Puavilai T, Bedavanija A, Garcia-Herrera A, Campo E, Cook JR, Choi J, Swerdlow SH. Am J Surg Pathol. 2012 Apr; 36(4):481-99.
9. Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis. Nicolini FE, Masszi T, Shen Z, Gallagher NJ, Jootar S, Powell BL, Dorlhiac-Llacer PE, Zheng M, Szczudlo T, Turkina A. Leuk Lymphoma. 2012 May;53(5):907-14.
10. Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase. Nicolini FE, Turkina A, Shen ZX, Gallagher N, Jootar S, Powell BL, De Souza C, Zheng M, Szczudlo T, le Coutre P. Cancer. 2012 Jan 1;118(1):118-26.
11. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. EINSTEIN–PE Investigators., Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A. N Engl J Med. 2012 Apr 5;366(14):1287-97.
12. Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy. Horne BD, Lenzini PA, Wadelius M, Jorgensen AL, Kimmel SE, Ridker PM, Eriksson N, Anderson JL, Pirmohamed M, Limdi NA, Pendleton RC, McMillin GA, Burmester JK, Kurnik D, Stein CM, Caldwell MD, Eby CS, Rane A, Lindh JD, Shin JG, Kim HS, Angchaisuksiri P, Glynn RJ, Kronquist KE, Carlquist JF, Grice GR, Barrack RL, Li J, Gage BF. Thromb Haemost. 2012 Feb;107(2):232-40.
13. Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease. Chantrathammachart P, Mackman N, Sparkenbaugh E, Wang JG, Parise LV, Kirchhofer D, Key NS, Pawlinski R. Blood. 2012 Jul 19;120(3):636-46.
14. Studies on the mechanism of action of the aptamer BAX499, an inhibitor of tissue factor pathway inhibitor. Chang JY, Chantrathammachart P, Monroe DM, Key NS. Thromb Res. 2012 Sep;130(3):e151-7.
15. Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Wang JG, Geddings JE, Aleman MM, Cardenas JC, Chantrathammachart P, Williams JC, Kirchhofer D, Bogdanov VY, Bach RR, Rak J, Church FC, Wolberg AS, Pawlinski R, Key NS, Yeh JJ, Mackman N. Blood. 2012 Jun 7;119(23):5543-52.
16. Tissue factor and thrombin in sickle cell anemia. Chantrathammachart P, Pawlinski R. Thromb Res. 2012 May;129 Suppl 2:S70-2.

2011

1. Activation of mononuclear phagocytes and its relationship to asplenia and phosphatidylserine exposing red blood cells in hemoglobin E/β-thalassemia patients. Banyatsuppasin W, Butthep P, Atichartakarn V, Thakkinstian A, Archararit N, Pattanapanyasat K, Chuncharunee S. Am J Hematol. 2011 Jan; 86(1):89-92.
2. Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis.Nicolini FE, Masszi T, Shen Z, Gallagher NJ, Jootar S, Powell BL, Dorlhiac-Llacer PE, Zheng M, Szczudlo T, Turkina A. Leuk Lymphoma. 2011 Dec 5.
3. Expanding Nilotinib Access in Clinical Trials (ENACT): An open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase. Nicolini FE, Turkina A, Shen ZX, Gallagher N, Jootar S, Powell BL, De Souza C, Zheng M, Szczudlo T, le Coutre P. Cancer. 2011 Jul 5.
4. Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies. Praditpornsilpa K, Tiranathanagul K, Kupatawintu P, Jootar S, Intragumtornchai T, Tungsanga K, Teerapornlertratt T, Lumlertkul D, Townamchai N, Susantitaphong P, Katavetin P, Kanjanabuch T, Avihingsanon Y, Eiam-Ong S. Kidney Int. 2011 Jul; 80(1):88-92. Epub 2011 Mar 23.
5. DNA detection of chronic myelogenous leukemia by magnetic nanoparticles. Jangpatarapongsa K, Polpanich D, Yamkamon V, Dittharot Y, Peng-On J, Thiramanas R, Hongeng S, Jootar S, Charoenmak L, Tangboriboonrat P. Analyst. 2011 Jan 21;136(2):354-8. Epub 2010 Oct 21.
6. Sarcoidosis-associated MHC Ags and the development of cutaneous and nodal granulomas following allogeneic hematopoietic cell transplant. Pukiat S, McCarthy PL Jr, Hahn T, Morrison C, Shanahan T, Qiu J, Liu H. Bone Marrow Transplant. 2011 Jul;46(7):1032-4.

2010

1. DNA detection of chronic myelogenous leukemia by magnetic nanoparticles. Jangpatarapongsa K, Polpanich D, Yamkamon V, Dittharot Y, Peng-On J, Thiramanas R, Hongeng S, Jootar S, Charoenmak L, Tangboriboonrat P. Analyst. 2011 Jan 21;136(2):354-8. Epub 2010 Oct 21.
2. Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients. Niparuck P, Kanoksil W, Chuncharunee S, Boonsakan P, Ungkanont A, Angchaisuksiri P, Karntisaviwat K, Apilugsanachit A, Rerkamnuatchoke B, Jootar S, Nitiyanant P, Atichartakarn V. Leuk Lymphoma. 2010 Nov; 51(11):2120-5. Epub 2010 Sep 17.
3. Transcoronary infusion of bone marrow derived multipotent stem cells to preserve left ventricular geometry and function after myocardial infarction. Boonbaichaiyapruck S, Pienvichit P, Limpijarnkij T, Rerkpattanapipat P, Pongpatananurak A, Saelee R, Ungkanont A, Hongeng S. Clin Cardiol. 2010 Jul; 33(7): E10-5.
4. Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy era. Kim DW, Banavali SD, Bunworasate U, Goh YT, Ganly P, Huang H, Irving I, Jootar S, Goh HG, Koh LP, Li W, Naoe T, Ng SC, Purushotaman V, Reksodiputro H, Shih LY, Tang JL, Tojo A, Wang J, Wong R. Leuk Res. 2010 Nov; 34(11): 1459-71.
5. Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand. Niparuck P, Sorakhunpipitkul L, Atichartakarn V, Chuncharunee S, Ungkanont A, Aungchaisuksiri P, Puavilai T, Jootar S. J Hematol Oncol. 2010 Jan 5;3:1.
6. Intravascular B-cell lymphoma presenting with cauda equina syndrome: the role of skin biopsy. Piyatanont K, Bamrungrak K, Watcharananan S, Sathapatayavongs B, Chuncharunee S, Larbcharoensub N, Witoonpanich R. Eur J Dermatol. 2010 Nov-Dec;20(6):821-2.
7. International reproducibility of single breathhold T2* MR for cardiac and liver iron assessment among five thalassemia centers. Kirk P, He T, Anderson LJ, Roughton M, Tanner MA, Lam WW, Au WY, Chu WC, Chan G, Galanello R, Matta G, Fogel M, Cohen AR, Tan RS, Chen K, Ng I, Lai A, Fucharoen S, Laothamata J, Chuncharunee S, Jongjirasiri S, Firmin DN, Smith GC, Pennell DJ. J Magn Reson Imaging. 2010 Aug;32(2):315-9.
8. Hb Tak and Hb Q-Thailand in Thai patients are S-window hemoglobin variants revealed by high performance liquid chromatography. Jindadamrongwech S, Tungbuppha N, Chuncharunee S, Butthep P. Hemoglobin. 2010 Jan;34(2):161-4.
9. Oral rivaroxaban for symptomatic venous thromboembolism. EINSTEIN Investigators., Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S. N Engl J Med. 2010 Dec 23;363(26):2499-510.
10. Integration of genetic, clinical, and INR data to refine warfarin dosing. Lenzini P, Wadelius M, Kimmel S, Anderson JL, Jorgensen AL, Pirmohamed M, Caldwell MD, Limdi N, Burmester JK, Dowd MB, Angchaisuksiri P, Bass AR, Chen J, Eriksson N, Rane A, Lindh JD, Carlquist JF, Horne BD, Grice G, Milligan PE, Eby C, Shin J, Kim H, Kurnik D, Stein CM, McMillin G, Pendleton RC, Berg RL, Deloukas P, Gage BF. Clin Pharmacol Ther. 2010 May;87(5):572-8.
11. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Bergmann JF, Cohen AT, Tapson VF, Goldhaber SZ, Kakkar AK, Deslandes B, Huang W, Anderson FA Jr; ENDORSE Investigators. Thromb Haemost. 2010 Apr;103(4):736-48.
12. Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors. Chuansumrit A, Angchaisuksiri P, Sirachainan N. J Blood Med. 2010;1:37-48.
13. Membrane microparticles in VTE and cancer. Key NS, Chantrathammachart P, Moody PW, Chang JY. Thromb Res. 2010 Apr;125 Suppl 2:S80-3. doi: 10.1016/S0049-3848(10)70020-7. Review.
14. Diffuse large B-cell lymphoma presenting as pancoast tumor. Ngamphaiboon N, Pukiat S, Kandimalla Y, Hernandez-Ilizaliturri FJ, Rooney JJ. J Clin Oncol. 2010 Jun 1;28(16):e254-6.

2009

1. Long-term outcomes of de novo acute myeloid leukemia in Thai patients. Niparuck P, Chuncharunee S, Ungkanont A, Udomtrupayakul U, Aungchaisuksiri P, Rerkamnuatchoke B, Jootar S, Atichartakarn V. J Med Assoc Thai. 2009 Sep;92(9):1143-9.

2. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R). Kantarjian H, Pasquini R, Lévy V, Jootar S, Holowiecki J, Hamerschlak N, Hughes T, Bleickardt E, Dejardin D, Cortes J, Shah NP. Cancer. 2009 Sep 15;115(18):4136-47.

3. Clinical profile of dasatinib in Asian and non-Asian patients with chronic myeloid leukemia. Kim DW, Goh YT, Hsiao HH, Caguioa PB, Kim D, Kim WS, Saikia T, Agrawal S, Roy A, Dai D, Bradley-Garelik MB, Mukhopadhyay J, Jootar S. Int J Hematol. 2009 Jun;89(5):664-72.

4. Chronic myeloid leukemia in Asia. Au WY, Caguioa PB, Chuah C, Hsu SC, Jootar S, Kim DW, Kweon IY, O'Neil WM, Saikia TK, Wang J. Int J Hematol. 2009 Jan;89(1):14-23.

5. The combined use of Flu/ATG in nonmyeloablative SCT for severe aplastic anemia with multiple earlier transfusions. Niparuck P, Ungkanont A, Ativitavas T, Jootar S. Bone Marrow Transplant. 2009 Jun;43(11):887-9.

6. The association of anti-r-HuEpo-associated pure red cell aplasia with HLA-DRB1*09-DQB1*0309. Praditpornsilpa K, Kupatawintu P, Mongkonsritagoon W, Supasyndh O, Jootar S, Intarakumthornchai T, Pongskul C, Prasithsirikul W, Achavanuntakul B, Ruangkarnchanasetr P, Laohavinij S, Eiam-Ong S. Nephrol Dial Transplant. 2009 May;24(5):1545-9.

2008

1. High dose chemotherapy and peripheral blood stem cell transplantation for high risk primary breast cancer: a single center experience in Thailand. Ungkanont A, Jootar S, Ratanatharathorn V, Chiernsilp A. Asian Pac J Allergy Immunol. 2000 Dec;18(4):215-20.
2. Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myeloablative conditioning regimen. Ungkanont A, Mongkonsritrakoon W, Jootar S, Srichaikul T. Bone Marrow Transplant. 2000 Dec;26(12):1351-4.
3. Etiology and incidence of thrombotic and hemorrhagic disorders in Thai patients with extreme thrombocytosis. Chuncharunee S, Archararit N, Ungkanont A, Jootar S, Angchaisuksiri P, Bunyaratavej A, Rojanasthein S, Atichartakarn V. J Med Assoc Thai. 2000 Mar;83 Suppl 1:S95-100.
4. Nursing roles in orthopaedic joint correction in haemophiliac patients. Kuhathong K, Chuansumrit A, Keorochana S, Pornpipatpong N, Pitakjaroen M, Suwannurak M, Angchaisuksiri P, Isarangkura P. Haemophilia. 2000 Nov;6(6):672-6.
5. Prevalence of the C677T methylenetetrahydrofolate reductase mutation in Thai patients with deep vein thrombosis. Angchaisuksiri P, Pingsuthiwong S, Sura T, Aryuchai K, Busabaratana M, Atichartakarn V. Acta Haematol. 2000;103(4):191-6.
6. Prevalence of the G1691A mutation in the factor V gene (factor V Leiden) and the G20210A prothrombin gene mutation in the Thai population. Angchaisuksiri P, Pingsuthiwong S, Aryuchai K, Busabaratana M, Sura T, Atichartakarn V, Sritara P. Am J Hematol. 2000 Oct;65(2):119-22.
7. Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection. Chuansumrit A, Isarangkura P, Angchaisuksiri P, Sriudomporn N, Tanpowpong K, Hathirat P, Jorgensen LN. Haemophilia. 2000 Mar;6(2):61-5.

1999

1. Serum erythropoietin levels in thalassemia major and intermedia. Chaisiripoomkere W, Jootar S, Chancharunee S, Ungkanont A. Southeast Asian J Trop Med Public Health. 1999 Dec;30(4):786-8.
2. Study of hematopoietic progenitor cells, hematological values and lymphocyte subsets in cord blood: application for cord blood transplantation. Chaisiripoomkere W, Jootar S, Ungkanont A, Jaovisidha A, Onpun S, Khupulsup K. Southeast Asian J Trop Med Public Health. 1999 Dec;30(4):781-5.
3. Delayed administration of G-CSF in both mobilization and post transplantation in autologous peripheral blood stem cell transplantation. Ungkanont A, Jootar S, Chuncharunee S, Chaisiripoomkere W. Asian Pac J Allergy Immunol. 1999 Dec;17(4):289-93.
4. Allogeneic peripheral blood stem cell transplantation in a Wiskott-Aldrich syndrome patient. Hongeng S, Pakakasama S, Hathirat P, Chaisiripoomkere W, Ungkanont A. Bone Marrow Transplant. 1999 Aug;24(4):445-6.
5. Indices of iron status in continuous ambulatory peritoneal dialysis patients. Domrongkitchaiporn S, Jirakranont B, Atamasrikul K, Ungkanont A, Bunyaratvej A. Am J Kidney Dis. 1999 Jul;34(1):29-35.

1998

1. Allogeneic bone marrow transplantation in an osteopetrosis patient: first report in Thailand. Hongeng S, Pakakasama S, Chuansumrit A, Rerkamnuaychoke B, Nitiyanunt P, Suthutvoravut U, Ungkanont A, Hathirat P. Asian Pac J Allergy Immunol. 1998 Dec;16(4):193-8

1996

1. Multivariate analysis of prognostic factors in Philadelphia chromosome positive chronic myeloid leukemia: an update of the first series in Thailand. Jootar S, Ungkanont A, Chuncharunee S, Atichartakarn V. Asian Pac J Allergy Immunol. 1996 Jun;14(1):25-30.
2. Use of plasma exchange in hereditary deficiency of factor V and factor VIII. Sallah AS, Angchaisuksiri P, Roberts HR. Am J Hematol. 1996 Jul;52(3):229-30.
3. Effects of recombinant human thrombopoietin on megakaryocyte colony formation and megakaryocyte ploidy by human CD34+ cells in a serum-free system. Angchaisuksiri P, Carlson PL, Dessypris EN. Br J Haematol. 1996 Apr;93(1):13-7.

1994

1. Replication and endoreplication in developing megakaryocytes in vitro. Angchaisuksiri P, Carlson PL, Day EB, Dessypris EN. Exp Hematol. 1994 Jul;22(7):546-50.

1993

1. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital. Angchaisuksiri P, Atichartakarn V, Pathepchotiwong K, Jootar S, Ungkanont A, Chuncharunee S. Southeast Asian J Trop Med Public Health. 1993;24 Suppl 1:152-8.
2. HIV infection after autologous bone marrow transplantation despite HIV-antibody and HIV-antigen screening. Jootar S, Angchaisuksiri P, Chiewsilp P, Sathapatayavongs B, Chuncharunee S, Tanprasert S. Bone Marrow Transplant. 1993 Aug;12(2):167-8.

1992

1. Bone marrow transplantation in Ramathibodi Hospital: progress report. Jootar S, Chuncharunee S, Ungkanont A, Tanapothiwirut W, Chiewsilp P. Asian Pac J Allergy Immunol. 1992 Dec;10(2):117-22.
2. Anti-HIV seroconversion in hemophilia A patient after transfusion of anti-HIV negative blood components. Ungkanont A, Atichartakarn V, Chiewsilp P. J Med Assoc Thai. 1992 Feb;75(2):120-2.